Autosomal dominant polycystic kidney disease (ADPKD), the most common form of polycystic kidney disease, can lead to kidney enlargement and eventual loss of function.
Switzerland: Chronic treatment with Tolvaptan is tied to an increased femoral bone mineral density (BMD), and remarkable changes in both acid-base parameters and mineral metabolism in patients with.